Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

40%

2 of 5 completed trials have results

Key Signals

3 recruiting2 with results

Enrollment Performance

Analytics

N/A

3(33.3%)

Phase 4

3(33.3%)

Phase 2

2(22.2%)

Phase 3

1(11.1%)

9Total

N/A(3)

Phase 4(3)

Phase 2(2)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06323824Phase 4Recruiting

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Role: collaborator

NCT06768021Not ApplicableCompleted

Does Style of Pre-sedation Instructions Improve Patient Outcomes in Ambulatory Anesthesia for Oral and Maxillofacial Surgery?

Role: lead

NCT06827288Not ApplicableRecruiting

Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder

Role: collaborator

NCT06494904Phase 3Recruiting

Standard Versus High Dose ED-Initiated Buprenorphine Induction

Role: collaborator

NCT04225598Phase 2Completed

Emergency Department-Initiated Buprenorphine Validation Network Trial

Role: collaborator

NCT05284838Not ApplicableCompleted

Facilitating Adaptive Expertise in Learning Computed Tomography

Role: collaborator

NCT02916927Phase 4Completed

Intravenous Sub-dissociative Dose Ketamine Injection Versus Infusion for Analgesia in the Emergency Department

Role: lead

NCT02912195Phase 4Completed

Intravenous Lidocaine Versus Morphine for Severe Pain in the ED

Role: lead

NCT03256487Phase 2Unknown

Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department

Role: lead

All 9 trials loaded